CME Group Inc. (NASDAQ:CME) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 2.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 125,157 shares of the financial services provider’s stock after buying an additional 2,550 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in CME Group were worth $26,358,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Naples Global Advisors LLC boosted its position in shares of CME Group by 5.6% during the fourth quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock worth $436,000 after buying an additional 110 shares during the period. Sapient Capital LLC purchased a new position in shares of CME Group during the fourth quarter worth $1,823,000. FNY Investment Advisers LLC purchased a new position in shares of CME Group during the fourth quarter worth $1,074,000. Deutsche Bank AG boosted its position in shares of CME Group by 4.3% during the third quarter. Deutsche Bank AG now owns 1,118,104 shares of the financial services provider’s stock worth $223,867,000 after buying an additional 46,021 shares during the period. Finally, International Assets Investment Management LLC purchased a new position in shares of CME Group during the fourth quarter worth $27,986,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on CME shares. Keefe, Bruyette & Woods restated a “market perform” rating and set a $229.00 price target on shares of CME Group in a research report on Wednesday, April 3rd. Barclays raised their price target on CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a research report on Monday, April 8th. Argus lifted their target price on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. Morgan Stanley lifted their target price on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a report on Tuesday, April 9th. Finally, The Goldman Sachs Group lowered CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a report on Wednesday, January 3rd. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, CME Group has a consensus rating of “Hold” and a consensus price target of $215.70.

Get Our Latest Research Report on CME Group

CME Group Trading Up 0.9 %

NASDAQ:CME opened at $208.42 on Thursday. The firm has a market cap of $75.03 billion, a PE ratio of 23.50, a price-to-earnings-growth ratio of 5.86 and a beta of 0.49. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a fifty day moving average price of $214.15 and a 200 day moving average price of $211.63. CME Group Inc. has a 12-month low of $175.73 and a 12-month high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.10. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. CME Group had a return on equity of 12.32% and a net margin of 57.83%. CME Group’s revenue for the quarter was up 19.2% on a year-over-year basis. During the same period in the previous year, the business earned $1.92 EPS. Sell-side analysts anticipate that CME Group Inc. will post 9.56 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.21%. This is an increase from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date of this dividend was Thursday, March 7th. CME Group’s payout ratio is 51.86%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.